Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

Title
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
Authors
Keywords
-
Journal
VACCINE
Volume 30, Issue 39, Pages 5761-5769
Publisher
Elsevier BV
Online
2012-07-11
DOI
10.1016/j.vaccine.2012.06.086

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now